KR20000044985A - Composition for prevention and treatment of dermatophytosis comprising extracts of belamcanda chinensis, aurantiilmmaturi pericapium, sanguisorbae radix, cnidii fructus and schisandra chinensis - Google Patents

Composition for prevention and treatment of dermatophytosis comprising extracts of belamcanda chinensis, aurantiilmmaturi pericapium, sanguisorbae radix, cnidii fructus and schisandra chinensis Download PDF

Info

Publication number
KR20000044985A
KR20000044985A KR1019980061492A KR19980061492A KR20000044985A KR 20000044985 A KR20000044985 A KR 20000044985A KR 1019980061492 A KR1019980061492 A KR 1019980061492A KR 19980061492 A KR19980061492 A KR 19980061492A KR 20000044985 A KR20000044985 A KR 20000044985A
Authority
KR
South Korea
Prior art keywords
extract
extracts
composition
athlete
fat milk
Prior art date
Application number
KR1019980061492A
Other languages
Korean (ko)
Other versions
KR100564225B1 (en
Inventor
박상기
김상년
김정훈
김민주
Original Assignee
성재갑
주식회사 엘지화학
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 성재갑, 주식회사 엘지화학 filed Critical 성재갑
Priority to KR1019980061492A priority Critical patent/KR100564225B1/en
Publication of KR20000044985A publication Critical patent/KR20000044985A/en
Application granted granted Critical
Publication of KR100564225B1 publication Critical patent/KR100564225B1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/88Liliopsida (monocotyledons)
    • A61K36/896Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
    • A61K36/8965Asparagus, e.g. garden asparagus or asparagus fern
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/23Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/73Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
    • A61K36/739Sanguisorba (burnet)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/75Rutaceae (Rue family)
    • A61K36/752Citrus, e.g. lime, orange or lemon
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/79Schisandraceae (Schisandra family)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/08Solutions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/10Preparation or pretreatment of starting material
    • A61K2236/15Preparation or pretreatment of starting material involving mechanical treatment, e.g. chopping up, cutting or grinding
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/30Extraction of the material
    • A61K2236/33Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
    • A61K2236/333Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using mixed solvents, e.g. 70% EtOH
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

PURPOSE: A composition for prevention and treatment of dermatophytosis is provided which includes the plant extracts having antibiotic effects on trichophyton mentagro phytes and epidermophyton floccosum. CONSTITUTION: A composition includes 0.01-10 wt.% of more than one plant extract among Belamcanda chinensis, Aurantiilmmaturi Pericapium, Sanguisorbae radix, Cnidii fructus And Schisandra chinensis. The extracts is manufactured by the following steps: 1) grinding(10-200 mesh) dried plants, 2) extracting the grinded plants with one solvent among water, methanol, ethanol, propanol, butanol, glycerol, ethylene glycol, propylene glycol, 1,3-butylene glycol, methyl acetate, ethyl acetate, benzene, hexane, diethyl ether, dichloromethane, and acetone, 3) filtering the extracts, 4) concentrating the extracts.

Description

사간, 청피, 지유, 사상자, 오미자 추출물을 함유하는 무좀, 습진 예방 및 치료용 조성물Athlete's foot, eczema prevention and treatment composition

[산업상 이용분야][Industrial use]

본 발명은 사간(射干), 청피(靑皮), 지유(地楡), 사상자(蛇床 子), 오미자(五味子)로부터 식물 추출물을 얻는 방법과 이 추출물을 함유한 조성물에 관한 것이다. 특히 무좀 습진의 주 원인균으로 알려진 트리코피톤 멘타그로파이트(trichophyton mentagrophytes) 및 에피더모피톤 플로코섬(epidermophyton floccosum)의 생육을 저해하여 무좀 습진의 예방 및 치료에 유효한 효과를 나타내는 무좀 습진 예방 및 치료용 조성물에 관한 것이다.The present invention relates to a method for obtaining a plant extract from dead skin, green skin, fat milk, casualty, and Schisandra chinensis and a composition containing the extract. In particular, it inhibits the growth of trichophyton mentagrophytes and epidermophyton floccosum, which are known as the main causative agents of athlete's foot eczema, for preventing and treating athlete's foot eczema, which is effective in preventing and treating athlete's foot eczema. It relates to a composition.

[종래 기술][Prior art]

무좀은 가장 흔히 관찰되는 진균 감염 증상의 하나이다. 무좀 습진의 원인균은 피부에 친화력을 갖는 곰팡이(더마토파이트) 중에서 주로 트리코피톤 루브룸, 트리코피톤 메타그로파이트 및 에피더모피톤 플로코섬이며, 이들이 피부의 각질에 침투하여 가려움, 발적, 염증 등의 증상을 일으킨다고 한다.Athlete's foot is one of the most common symptoms of fungal infections. The causative agents of athlete's foot eczema are trichophyton rubrum, trichophyton metagrophyte and epidermophytone phlocosome, among the fungi (dermatophytes) having affinity for skin, and they penetrate keratin of skin and cause itching, redness, inflammation, etc. It is said to cause symptoms.

이들 더마토파이트의 감염증이 악화되는 정도는 감염 부위의 환경, 또 다른 기회 감염균의 동시 감염 및 개인적인 면역 능력에 따라 달라진다.The exacerbation of these dermatophyte infections depends on the environment of the site of infection, the simultaneous infection of another opportunistic organism, and the individual's ability to immunize.

신발, 양말 등에 의한 폐쇄는 감염 부위의 열과 습기를 증가시켜 더마토파이트의 증식을 항진시킨다.Closures by shoes, socks, etc. increase the heat and humidity of the affected area and promote the growth of dermatophyte.

문헌(Clin. Exp. Dermatol. 17, 1992)에 의하면 이러한 무좀 습진은 어린 아이들보다는 어른들에게서 잘 나타나며, 선진국 성인 인구의 10 내지 15 %가 무좀 습진을 갖고 있거나 감염 경험이 있다고 알려져 있다.According to Clin. Exp. Dermatol. 17, 1992, such athlete's foot eczema is more pronounced in adults than in young children, and 10 to 15% of the adult population of developed countries have athlete's foot eczema or have been infected.

무좀 습진을 치료하기 위해서는 무좀 습진의 원인균을 죽이거나 균의 성장을 억제하는 방법이 고려된다. 여기에서 각질 연화제를 함께 사용하여 무좀균이 살고 있는 각질을 탈락시키거나 증상을 호전시키기 위하여 스테로이드 제제를 겸하여 사용하기도 한다. 그리고 감염 부위를 잘 씻고 건조시킴으로써 감염 부위의 열과 습기를 낮추어 무좀 습진균의 증식에 불리한 조건을 만드는 것도 무좀 습진의 치료에 도움을 줄 수 있다.In order to treat athlete's foot eczema, a method of killing the causative agent of athlete's foot eczema or inhibiting the growth of bacteria is considered. In this case, a keratin softener may be used together to remove stratum corneum where the athlete's foot fungus lives or to improve symptoms. Also, by washing and drying the affected area well, lowering the heat and humidity of the infected area to create an unfavorable condition for the growth of athlete's foot eczema may also help treat athlete's foot eczema.

무좀 습진 치료제로서 항진균제 및 살리실산 등이 처방된 외용액제, 연고, 스프레이 등이 이미 개발되어 상용화되었으나, 무좀은 대개의 경우 치료 후에 겉으로 증상이 나타나지 않다가도 재발되어 꾸준히 치료하지 않으면 완치가 어렵다.As a treatment for athlete's foot eczema, antifungal agents and salicylic acid-prescribed external preparations, ointments, and sprays have already been developed and commercialized. However, athlete's foot is difficult to cure without recurring treatment without recurring symptoms.

그러므로 무좀 습진을 완전하게 치료하기 위해서 증상이 호전된 후에도 지속적으로 항진균제 등을 사용하여 치료하는 동시에 재감염을 막는 것이 필요하다.Therefore, in order to completely treat athlete's foot eczema, it is necessary to continue treatment with antifungal agents even after symptom improvement to prevent re-infection.

따라서 본 발명의 목적은 상기의 문제점을 고려하여 무좀 습진의 원인균으로 알려진 트리코피톤 멘타그로파이트 및 에피더모피톤 프로코섬에 대하여 특이적인 항균 작용을 갖고 장기간 사용하여도 인체에 안전성이 높은 물질로서 각종 한방 약제 및 식물들을 대상으로 연구하여 사간, 청피, 지유, 사상자, 오미자 추출물이 무좀 습진균에 대하여 낮은 농도에서도 우수한 항균 효과가 있음을 발견하여 이들 식물들의 추출 물을 얻는 방법 및 이들 추출물을 함유한 예방 및 치료제 조성물을 제공하는 것이다.Therefore, the object of the present invention has a specific antimicrobial activity against trichophyton mentagrophyte and epidermophytone procosome known as causative bacteria of athlete's foot eczema in consideration of the above problems and has a high safety for human body even after long-term use. Herbal medicines and plants were studied to find out that the liver, green skin, fat milk, casualty and schizandra extracts have excellent antimicrobial effects even at low concentrations against athlete's foot fungus. It is to provide a prophylactic and therapeutic composition.

[과제를 해결하기 위한 수단][Means for solving the problem]

본 발명은 상기 목적을 달성하기 위하여 사간, 청피, 지유, 사상자, 오미자로 이루어진 군으로부터 1 종 이상 선택되는 식물 추출물을 0.01∼10 중량% 포함하여 무좀 습진 원인균인 트리코피톤 멘타그로파이트 및 에피더모피톤 플로코섬에 대하여 항균 효과를 나타내는 무좀 습진 예방 및 치료용 조성물을 제공한다.The present invention comprises 0.01 to 10% by weight of one or more plant extracts selected from the group consisting of dead liver, green skin, fat milk, casualties, and Schizandra chinensis to cause athlete's foot eczema tricophyton mentagrophyte and epidermomorph to achieve the above object. It provides a composition for preventing and treating athlete's foot eczema exhibiting an antimicrobial effect on ton flocosum.

상기에서 사간, 청피, 지유, 사상자, 오미자 추출물은Sagan, blue skin, fat milk, casualties, Schisandra chinensis extract is

a) 건조된 사간, 청피, 지유, 사상자, 오미자로 이루어진 군으로부터 선택되 는 식물 약제를 분쇄기로 10 내지 200 메쉬 크기의 분말로 분쇄하는 단계;a) pulverizing the plant medicament selected from the group consisting of dried loin, ground skin, fat milk, casualty and schizandra into powder of 10 to 200 mesh size with a grinder;

b) 분쇄된 약제를 용매에 48 시간 이상 냉침하여 추출하는 단계;b) extracting the pulverized agent by cooling in a solvent for at least 48 hours;

c) 추출액을 여과하는 단계; 및c) filtering the extract; And

d) 여과된 추출액을 감압 농축하는 단계d) concentrating the filtered extract under reduced pressure

를 포함하는 방법으로 제조된다.It is prepared by a method comprising a.

또한 상기에서 추출 용매가 정제수, 메탄올, 에탄올, 프로판올, 부탄올, 글리세롤, 에틸렌 글리콜, 프로필렌글리콜, 1,3-부틸렌글리콜, 메틸아세테이트, 에틸아세테이트, 벤젠, 헥산, 디에틸에테르, 디클로로메탄, 아세톤으로 이루어진 군으로부터 1 종 이상 선택된다.In addition, the extraction solvent is purified water, methanol, ethanol, propanol, butanol, glycerol, ethylene glycol, propylene glycol, 1,3-butylene glycol, methyl acetate, ethyl acetate, benzene, hexane, diethyl ether, dichloromethane, acetone At least one selected from the group consisting of.

본 발명은 하기에서 상세하게 설명한다.The invention is described in detail below.

본 발명은 무좀 습진 원인균에 대하여 우수한 항균력을 갖는 사간, 청피, 지유, 사상자, 오미자 추출물 및 이들 추출물을 함유하는 무좀 습진 예방 및 치료용 조성물에 관한 것이다.The present invention relates to a mortar, blue skin, fat milk, casualty, Schizandra extract having an excellent antimicrobial activity against athlete's foot eczema causing bacteria and a composition for preventing and treating athlete's foot eczema containing these extracts.

본 발명에 의한 무좀 예방 및 치료용 비누는 감염부위를 씻음과 동시에 약물을 적용할 수 있으므로 감염부위에서의 약물의 침투가 용이할 뿐 아니라 무좀 치료시에 가장 문제가 되는 지속적인 약물 적용의 번거로움을 해결할 수 있는 장점이 있다.Athlete's foot soap for preventing and treating athlete's foot according to the present invention can be applied to the drug at the same time as the washing of the infection site is easy to penetrate the drug in the infection site, and the hassle of the continuous drug application that is the most problematic when treating athlete's foot There is an advantage that can be solved.

본 발명에 사용되는 사간(belamcanda chinensis L.)은 붓꽃과 식물인 범부채의 뿌리줄기로서, 잔뿌리를 다듬어 햇볕에 말린 것이다. 알려진 화학성분은 벨람칸딘, 이리딘, 텍토리딘 등이며, 한방 및 민방에서 염증, 편도염 및 구취의 치료에 사용되어 왔다.The stem (belamcanda chinensis L.) used in the present invention is a root stem of an iris and a plant, which is a plant, and is dried in the sun by trimming fine roots. Known chemicals are belamcandine, iridine, tetolidine and the like, which have been used in the treatment of inflammation, tonsillitis and bad breath in Chinese and Korean medicine.

청피(citrus sp.)는 귤나무의 선열매 껍질을 말린 것이다. 알려진 화학성분은 레몬산, 리모넨, 헤스페리딘 등이며, 한방에서 방향성건위약, 기침가래약으로 사용되어 왔다.Citrus sp. Is the dried bark of the tangerine. Known chemicals are lemon acid, limonene, hesperidin and the like, and have been used in herbal medicine as an aromatic dry placebo and cough sputum medicine.

지유(sanguisorba officinalis L.)는 장미과의 오이풀의 뿌리 또는 뿌리줄기를 봄이나 가을에 캐서 햇볕에 말린 것이다. 알려진 화학성분은 탄닌류, 산귀소르빈, 비타민 C 등이며, 한방 및 민방에서 염증, 구강염의 치료 및 지혈에 사용되어 왔다.Fatty milk (sanguisorba officinalis L.) is a sun-dried root of the Root or Cucumber of the Rosaceae in spring or autumn. Known chemicals are tannins, acid sorbine, vitamin C, and the like, and have been used in the treatment of inflammation, oral inflammation and hemostasis in herbal and civil medicine.

사상자(cnidiummonnier cusson 또는 torilis japonica DC.)는 미나리아과의 별사상자의 열매이다. 알려진 화학성분은 α-피넨, l-캄펜 등의 정유와 쿠마린 등이며, 한방에서 음부질병 등의 치료에 사용되어 왔다.Casualties (cnidiummonnier cusson or torilis japonica DC.) Are the fruit of the Asteraceae. Known chemical components are essential oils such as α-pinene and l-camphor, coumarin and the like, and have been used in the treatment of genital diseases and the like in Chinese medicine.

오미자(schisandra chinensis baill)는 오미자과의 오미자 나무의 여문 열매를 햇볕에 말린 것이다. 알려진 화학성분은 레몬산, 사과산 등으 유기산과 시산드린, 시산드롤, 고미신 등이며, 한방에서 자양강장, 기관지염 등에 사용되어 왔다.Schizandra chinensis baill is a sun-dried fruit of the Schizandra chinensis. Known chemicals are lemon acid, malic acid, and other organic acids, cisandrones, cisandrol, gomisin, and the like, which have been used in oriental medicine, bronchitis, and the like.

이러한 상기의 사간, 청피, 지유, 사상자, 오미자는 오래전부터 한방에서 사용해온 재료로서 체내섭취에 따른 인체 안전성이 이미 확인된 식물이며, 피부 및 점막에 대한 자극도 거의 없는 안전한 식물들이며, 본 발명에서는 이들의 추출물을 함유한 무좀 습진 예방 및 치료용 조성물을 제공한다.The liver, green skin, fat milk, casualty, Schizandra chinensis, which has been used in herbal medicine for a long time, is a plant whose human safety has already been confirmed by ingestion of the body, and is a safe plant having little irritation to skin and mucous membranes. Provided is a composition for preventing and treating athlete's foot eczema containing an extract thereof.

본 발명의 조성물은 화장비누 베이스를 기본으로 상기 식물들의 추출물을 포함시킨 조성물이다. 추출물 함량은 0.01 중량% 미만인 경우에는 유의성이 있는 효과를 나타내지 못화며, 10 중량% 이상인 경우에는 함량 증가에 비하여 항균 효과의 증가폭이 낮아서 경제성이 낮다.The composition of the present invention is a composition comprising the extract of the plants based on the soap base. If the content of the extract is less than 0.01% by weight, it does not show a significant effect, and when the content is more than 10% by weight, the increase of the antimicrobial effect is low compared to the increase of the economic efficiency.

본 발명의 조성물은 통상의 베이스에 사간, 청피, 지유, 사상자, 오미자 추출물을 함유시킨 것이기 때문에 임상효과를 상승시키기 위하여 살리실산, 알파하이드록시산, 베타하이드록시산 또는 황 등의 피부 각질제거제 등을 선택하여 첨가할 수 있다. 또한 향료, 색소, 살균제, 산화 방지제, 보습제 및 물성 개선을 위한 점증제, 무기염류 또는 합성 고분자 물질 등을 선택하여 첨가할 수도 있다.Since the composition of the present invention contains the liver, green skin, fat milk, casualty, and Schisandra chinensis extract in a conventional base, skin exfoliants such as salicylic acid, alpha hydroxy acid, beta hydroxy acid or sulfur are used to enhance clinical effect. Can be added. In addition, flavors, pigments, fungicides, antioxidants, moisturizers and thickeners for improving physical properties, inorganic salts or synthetic polymer materials may be selected and added.

상기와 같이 사간, 청피, 지유, 사상자, 오미자 추출물을 포함하여 제조한 비누, 크림 등의 조성물은 무좀 습진의 원인균에 대하여 살균력 평가 및 무좀 습진 치료효과를 평가하기 위한 임상실험을 실시하였고, 그 결과 사간, 청피, 지유, 사상자, 오미자 추출물을 함유한 이들 조성물은 피부발적 등의 부작용이 나타나지 않았으며, 무좀 습진의 치료효과도 우수하였다.Compositions such as sagan, cheongpi, fat milk, casualty, Schisandra chinensis extract, soaps, creams, etc. composition was performed clinical trials to evaluate the bactericidal power and the therapeutic effect of athlete's foot eczema against causative bacteria of athlete's foot eczema, and as a result These compositions containing the liver, green skin, fat milk, casualty, and Schisandra chinensis extract did not show side effects such as skin redness, and also showed excellent therapeutic effect of athlete's foot eczema.

본 발명의 조성물은 서로 다른 제형인 액상, 크림상, 페이스트상 및 고체상 등의 어떠한 성상에도 적용이 가능하며, 통상적인 제조법에 용이하게 적용시킬 수 있는 것이다.The composition of the present invention can be applied to any of the properties, such as liquid, cream, paste, and solid, which are different formulations, and can be easily applied to conventional manufacturing methods.

이하 본 발명을 실시예 및 비교예에 의하여 더욱 구체적으로 설명한다. 단 이들 실시예는 본 발명을 예시하기 위한 것이며 본 발명이 이들만으로 한정되는 것은 아니다.Hereinafter, the present invention will be described in more detail with reference to Examples and Comparative Examples. However, these Examples are only for illustrating the present invention and the present invention is not limited thereto.

[실시예]EXAMPLE

실시예 1Example 1

사간, 청피, 지유, 사상자, 오미자 추출물의 제조Preparation of Sandan, Cheongpi, Fat Milk, Casualties, and Schizandra chinensis Extracts

건조시킨 사간, 청피, 지유, 사상자, 오미자 약재 각 500 g을 생약 분쇄기로 10 내지 200 메쉬의 크기로 분쇄하였다.500 g of dried sand, green skin, fat milk, filamentous and schizandra chinensis were ground to a size of 10 to 200 mesh using a herbal medicine grinder.

분쇄된 각각의 약재에 80 %(v/v) 에탄올 수용액 250 ㎖를 가하여 상온에서 48 시간 냉침시킨 후, 와트만 #2(whatman #2) 여과지와 진공 여과지를 이용하여 여과하였다.250 milliliters of an 80% (v / v) ethanol aqueous solution was added to the ground medicinal herbs, and the mixture was cooled at room temperature for 48 hours, and then filtered using a Whatman # 2 filter paper and a vacuum filter paper.

여과된 각각의 추출액을 45 ℃에서 감압 농축하여 100∼105 g의 추출물을 각각 얻었다.Each filtered extract was concentrated under reduced pressure at 45 ° C. to obtain 100-105 g of extract, respectively.

사간, 청피, 지유, 사상자, 오미자 추출물의 무좀 습진균에 대한 항균력 평가실험Evaluation of Antimicrobial Activity against Athlete's Foot Eczema by Sagan, Cheongpi, Fat Milk, Casualties, and Schizandra chinensis Extracts

상기에서 제조된 사간, 청피, 지유, 사상자, 오미자 추출물 각각을 무좀 습진균에 대한 항균력을 파악하기 위하여 종이 원반 시험(paper disk test)을 실시하였다.In order to determine the antimicrobial activity against athlete's foot fungi, paper disk test was carried out for each of the liver, green skin, fat milk, casualty and schizandra extracts prepared above.

시험균주인 트리코피톤 멘타그로파이트(trichophyton mentagrophytes) 및 에피더모피톤 플로코섬(epidermophyton floccosum)을 활성화하기 위하여 1 % 옥수수 오일(corn oil)을 함유한 감자 포도당액(potato dextrose broth) 배지에서 5 일 동안 전배양하였다.5 days in medium of potato dextrose broth containing 1% corn oil to activate test strains trichophyton mentagrophytes and epidermophyton floccosum. Pre-culture.

이렇게 준비한 균배양액을 고체배지(potato dextrose broth + 1.5 % agar) on)에 도말한 후 건조시켰다.The culture medium thus prepared was plated on a solid medium (potato dextrose broth + 1.5% agar) on and dried.

상기에서 제조한 사간, 청피, 지유, 사상자, 오미자 추출물 10 % 수용액을 각각 8 mm의 종이 원반에 40 ㎕ 씩 점적한 후 상기 고체 배지 위에 올려 놓고 30 ℃ 배양기에서 3 일간 배양하였다.40 μl each of the liver, green skin, fat milk, filamentous and Omija extract 10% aqueous solution prepared above was dropped onto 8 mm paper discs, and then placed on the solid medium and incubated in a 30 ° C. incubator for 3 days.

상기 종이 원반 주변에 생성된 균성장 저지 영역을 관찰하고 저지환의 크기를 측정하여 항균력을 평가하였다.The antimicrobial activity was evaluated by observing the bacterial growth inhibition region generated around the disc and measuring the size of the ring.

사간, 청피, 지유, 사상자, 오미자 추출물 10 % 수용액의 균성장 저지환의 크기를 표 1에 기재하였다.Table 1 shows the size of the bacterium growth inhibitory ring in 10% aqueous solution of liver, green skin, fat milk, filamentous and Schizandra chinensis extract.

[표 1]TABLE 1

구 분division 사간 추출물Sagan extract 청피 추출물Blue Skin Extract 지유 추출물Fat milk extract 사상자 추출물Casualty extract 오미자 추출물Schizandra Extract 시험균주의 생장 억제 및 포자 형성 억제 정도(균성장 저지환 크기, mm)Inhibition of growth and spore formation inhibition of test strain (bacterial growth ring size, mm) 트리코피톤 멘타그로파이트Trichophyton Mentagrophyte 2323 2525 2222 3131 2424 에피더모피톤 플로코섬Epidermophyton Floco Island 1212 2020 3737 3535 2828

실시예 2∼5, 비교예 1∼2Examples 2-5, Comparative Examples 1-2

비누의 제조Manufacture of soap

비누 베이스(수분 및 각종 첨가제 포함)와 실시예 1에서 제조된 각각의 식물 추출물을 하기 표 2의 조성비로 혼합기에서 잘 혼합한 후, 비누 제조기에서 압출, 절단, 형타하여 고형 비누 조성물을 제조하였다.Soap base (including moisture and various additives) and each of the plant extracts prepared in Example 1 were mixed well in a mixer in the composition ratio of Table 2 below, and then extruded, cut and molded in a soap maker to prepare a solid soap composition.

상기 추출물 각각을 일반 비누 뿐만 아니라 통상의 비누 제조 방법에 의하여 합성 비누와 복합비누에도 포함하여 제조할 수 있었다.Each of the extracts could be prepared by including not only general soap, but also synthetic soap and composite soap by a conventional soap manufacturing method.

[표 2]TABLE 2

구분원료(중량%)Raw material (% by weight) 실시예 2Example 2 실시예 3Example 3 실시예 4Example 4 실시예 5Example 5 비교예 1Comparative Example 1 비교예 2Comparative Example 2 비누 베이스Soap base 99.9999.99 99.9099.90 9999 9595 100100 99.99599.995 추출물extract 0.010.01 0.100.10 1One 55 00 0.0050.005 향 료(외삽)Spices (extrapolation) 적량Quantity 적량Quantity 적량Quantity 적량Quantity 적량Quantity 적량Quantity 색 소(외삽)Color (extrapolation) 적량Quantity 적량Quantity 적량Quantity 적량Quantity 적량Quantity 적량Quantity 산화방지제(외삽)(EDTA)Antioxidant (Extrapolated) (EDTA) 적량Quantity 적량Quantity 적량Quantity 적량Quantity 적량Quantity 적량Quantity

무좀 습진 원인균에 대한 항균력 평가 실험Evaluation of antimicrobial activity against athlete's foot eczema

상기에서 제조된 비누 조성물들에 대한 무좀 습진의 예방 및 치료효과를 확인하기 위하여 무좀 습진 원인균인 트리코피톤 멘타그로파이트 및 에피더모피톤 플로코섬에 대한 항균력 시험을 하기와 같이 실시하였다.In order to confirm the prophylactic and therapeutic effect of athlete's foot eczema on the soap compositions prepared above, the antibacterial activity test for trichophyton mentagrophyte and epidermophytone flocosum, which are athlete's foot eczema, was carried out as follows.

곰팡이용 배지에 상기에서 제조된 비누 조성물 5 % 수용액을 각각 첨가한 후에 각 배지에 활성화된 시험균주를 접종하여 30 ℃에서 3 일간 배양하면서 각 배지에서의 무좀 습진 원인균의 생장 양상을 비교하여 관찰하였다. 여기에서는 각각의 조성물에 대하여 5 개의 배지로 시험하여 평균값을 취하였다.After adding 5% aqueous solution of the soap composition prepared above to the fungal medium, the activated test strain was inoculated into each medium, and then cultured at 30 ° C. for 3 days, and the growth patterns of athlete's foot eczema in each medium were observed. . Here, each composition was tested with five media and the average value was taken.

무좀 습진 원인균에 대한 항균력은 무좀 습진 원인균의 생장 억제 정도로 평가하였다. 여기에서 상기의 추출물을 포함하지 않는 비누 조성물의 배지와 같이 무좀 습진 원인균의 생장이 억제되지 않은 경우로서 균이 잘 자라는 경우를 5, 균이 전혀 자라지 못하는 경우를 0 으로 하는 기준으로 균의 생장 정도에 따라서 상대적인 0, 1, 2, 3, 4, 5 의 점수를 주고, 조성물당 다섯 개 배지의 평균점수가 2 이하일 때 효과가 있는 것으로 평가하였다.Antibacterial activity against athlete's foot eczema was evaluated as the degree of inhibition of the growth of athlete's foot eczema. Here, the growth of the bacteria on the basis of the case where the growth of the fungus eczema causing bacteria is not inhibited as in the medium of the soap composition which does not include the extract as described above, 5 when the bacteria grow well and 0 when the bacteria do not grow at all. According to the relative score of 0, 1, 2, 3, 4, 5, it was evaluated as effective when the average score of five media per composition is 2 or less.

그 결과는 표 3에 나타내었다. 표 3의 결과는 실시예 1에서 제조된 사간, 청피, 지유, 사상자, 오미자 추출물들이 각각 동일한 항균 효과를 나타낸 것을 대표적인 평균 수치로 나타낸 것이다. 또한 상기 추출물들중 2 종 이상 선택하여 조합한 추출물을 사용하여 제조된 비누 조성물들도 동일한 결과를 나타내었다.The results are shown in Table 3. The results in Table 3 are representative average values of the liver, green skin, fat milk, casualty, Schizandra extract prepared in Example 1 exhibited the same antimicrobial effect, respectively. In addition, soap compositions prepared using extracts selected by combining two or more of the above extracts showed the same results.

[표 3]TABLE 3

구 분division 실시예 2Example 2 실시예 3Example 3 실시예 4Example 4 실시예 5Example 5 비교예 1Comparative Example 1 비교예 2Comparative Example 2 시험균주의 배지내 생장 정도Growth degree in the medium of the test strain 트리코피톤 멘타그로파이트Trichophyton Mentagrophyte 1.81.8 1One 0.20.2 00 55 44 에피더모피톤 플로코섬Epidermophyton Floco Island 1.81.8 1.21.2 0.40.4 00 55 4.24.2

실시예 6∼10, 비교예 3Examples 6-10, Comparative Example 3

크림의 제조Manufacture of cream

크림 베이스인 유성성분, 수성성분, 계면활성제 등의 조합물과 실시예 1에서 제조한 각각의 추출물들을 하기 표 4의 조성비로 혼합기에서 잘 유화시키고, 탈기, 여과, 냉각하여 크림 조성물을 제조하였다. 상기 조성에는 첨가제로서 방부체, 킬레이트제, 향료 및 색소가 첨가되었으며, 적은 양의 유성성분이 존재하도록 처방은 수중유형(oil/water)으로 제조하였다.Combination of cream base oil component, aqueous component, surfactant and the like and each extract prepared in Example 1 was emulsified well in a mixer in the composition ratio of Table 4 below, degassed, filtered, cooled to prepare a cream composition. Preservatives, chelating agents, fragrances and pigments were added to the composition as an additive, and the formulation was prepared in oil / water so that a small amount of oily components were present.

또한 일반적인 수중유형(oil/water)의 크림 베이스에 실시예 1에서 제조한 추출물들을 각각 또는 혼합하여 조성물내에 함유시키고, 향료, 색소, 산화방지제, 방부제 등을 첨가하여 제조할 수 있었으며, 물성 개선을 위하여 합성 또는 천연 소재를 첨가하여 제조할 수도 있었다.In addition, each of the extracts prepared in Example 1 or mixed in a common oil / water cream base may be contained in the composition, and the fragrance, pigments, antioxidants, preservatives, etc. could be added to improve the physical properties. It could also be prepared by the addition of synthetic or natural materials.

[표 4]TABLE 4

구분원료(중량%)Raw material (% by weight) 실시예 6Example 6 실시예 7Example 7 실시예 8Example 8 실시예 9Example 9 실시예10Example 10 비교예 3Comparative Example 3 스테아린산Stearic acid 88 88 88 88 88 88 스테아릴알코올Stearyl alcohol 44 44 44 44 44 44 스테아린산부틸Butyl stearate 66 66 66 66 66 66 프로필렌글리콜Propylene glycol 55 55 55 55 55 55 모노스테아린산글리세린Glycerin Monostearate 22 22 22 22 22 22 수산화칼륨Potassium hydroxide 0.400.40 0.400.40 0.400.40 0.400.40 0.400.40 0.400.40 추출물extract 0.010.01 0.100.10 1One 55 1010 00 정 제 수Purified water 74.5974.59 74.5074.50 73.6073.60 69.6069.60 64.6064.60 74.6074.60 향 료(외삽)Spices (extrapolation) 적량Quantity 적량Quantity 적량Quantity 적량Quantity 적량Quantity 적량Quantity 색 소(외삽)Color (extrapolation) 적량Quantity 적량Quantity 적량Quantity 적량Quantity 적량Quantity 적량Quantity 방 부 제(외삽)Preservative (extrapolation) 적량Quantity 적량Quantity 적량Quantity 적량Quantity 적량Quantity 적량Quantity

무좀 습진 원인균에 대한 항균력 평가 실험Evaluation of antimicrobial activity against athlete's foot eczema

상기에서 제조된 크림 조성물들에 대한 무좀 습진의 예방 및 치료효과를 확인하기 위하여 무좀 습진 원인균인 트리코피톤 멘타그로파이트 및 에피더모피톤 플로코섬에 대한 항균력 시험을 실시예 2∼5 및 비교예 1, 2 에서와 같이 실시하였다.In order to confirm the prophylactic and therapeutic effects of athlete's foot eczema on the cream compositions prepared above, the antibacterial activity test on trichophyton mentagrophyte and epidermophytone phlocosome, which are athlete's foot eczema, Examples 2 to 5 and Comparative Example 1 , 2 was carried out as in.

그 결과는 표 5에 나타내었다. 표 5의 결과는 실시예 1에서 제조된 사간, 청피, 지유, 사상자, 오미자 추출물들이 각각 동일한 항균 효과를 나타낸 것을 대표적인 평균 수치로 나타낸 것이다. 또한 상기 추출물들중 2 종 이상 선택하여 조합한 추출물을 사용하여 제조된 크림 조성물들도 동일한 결과를 나타내었다.The results are shown in Table 5. The results of Table 5 are representative average values of the liver, green skin, fat milk, casualty, Schizandra extract prepared in Example 1 each showed the same antimicrobial effect. In addition, cream compositions prepared using extracts selected by combining two or more of the above extracts showed the same result.

[표 5]TABLE 5

구 분division 실시예 6Example 6 실시예 7Example 7 실시예 8Example 8 실시예 9Example 9 실시예10Example 10 비교예 3Comparative Example 3 시험균주의 배지내 생장 정도Growth degree in the medium of the test strain 트리코피톤 멘타그로파이트Trichophyton Mentagrophyte 1.61.6 1.21.2 0.20.2 00 00 55 에피더모피톤 플로코섬Epidermophyton Floco Island 1.81.8 1.41.4 0.40.4 00 00 55

본 발명의 사간, 청피, 지유, 사상자, 오미자 추출물을 0.01∼10 중량% 포함한 조성물은 무좀 습진 원인균인 트리코피톤 멘타그로파이트 및 에피더모피톤 플로코섬에 대하여 우수한 항균 효과를 나타내어 무좀 습진의 예방 및 치료용으로 사용될 수 있다.Composition comprising 0.01 ~ 10% by weight of the liver, green skin, fat milk, casualty, Schizandra chinensis extract of the present invention exhibits excellent antimicrobial effect against trichophyton mentagrophyte and epidermophytone phlocosome, the causative eczema causative agents, to prevent athlete's foot eczema and It can be used for treatment.

특히, 비누 조성물은 감염부위를 씻음과 동시에 약물을 적용시킬 수 있어서 지속적인 약물 적용의 번거로움도 해소할 수 있다.In particular, the soap composition can be applied to the drug at the same time to wash the infected area, thereby eliminating the hassle of continuous drug application.

Claims (3)

사간 추출물, 청피 추출물, 지유 추출물, 사상자 추출물, 오미자 추출물로 이루어진 군으로부터 1 종 이상 선택되는 추출물이 함유되어 무좀 습진 원인균인 트리코피톤 멘타그로파이트(trichophyton mentagrophytes) 및 에피더모피톤 플로코섬(epidermophyton floccosum)에 대하여 항균 효과를 나타내는 무좀 습진 예방 및 치료용 조성물.Trichophyton mentagrophytes and epidermophyton floccosum, which are one or more extracts selected from the group consisting of sand extract, green skin extract, fat milk extract, casualty extract, and schizandra extract, which cause athlete's foot eczema Athlete's foot eczema preventive and therapeutic composition exhibiting an antimicrobial effect against). 제 1 항에 있어서,The method of claim 1, 상기 사간, 청피, 지유, 사상자 또는 오미자 추출물이 조성물 내에 0.01∼10 중량% 포함되는 조성물.The liver, green skin, fat milk, casualty or Schizandra extract is contained in the composition 0.01 to 10% by weight. 제 1 항에 있어서,The method of claim 1, 상기 사간, 청피, 지유, 사상자 또는 오미자 추출물이The liver, green skin, fat milk, casualty or Schisandra chinensis extract a) 건조된 사간, 청피, 지유, 사상자, 오미자로 이루어진 군으로부터 선택되 는 식물 약제를 분쇄기로 10 내지 200 메쉬 크기의 분말로 분쇄하는 단계;a) pulverizing the plant medicament selected from the group consisting of dried loin, ground skin, fat milk, casualty and schizandra into powder of 10 to 200 mesh size with a grinder; b) 분쇄된 약제를 정제수, 메탄올, 에탄올, 프로판올, 부탄올, 글리세롤, 에 틸렌글리콜, 프로필렌글리콜, 1,3-부틸렌글리콜, 메틸아세테이트, 에틸아 세테이트, 벤젠, 헥산, 디에틸에테르, 디클로로메탄, 아세톤으로 이루어 진 군으로부터 1 종 이상 선택되는 추출 용매에 48 시간 이상 냉침하 여 추출하는 단계;b) The pulverized drug is purified water, methanol, ethanol, propanol, butanol, glycerol, ethylene glycol, propylene glycol, 1,3-butylene glycol, methyl acetate, ethyl acetate, benzene, hexane, diethyl ether, dichloro Extraction by chilling for 48 hours or more in an extraction solvent selected from the group consisting of methane and acetone; c) 추출액을 여과하는 단계; 및c) filtering the extract; And d) 여과된 추출액을 감압 농축하는 단계d) concentrating the filtered extract under reduced pressure 를 포함하는 방법으로 제조되는 조성물.Composition prepared by the method comprising a.
KR1019980061492A 1998-12-30 1998-12-30 Athlete's foot, eczema prevention and treatment composition containing sagan, cheongpi, fat milk, casualty, Schisandra chinensis extract KR100564225B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR1019980061492A KR100564225B1 (en) 1998-12-30 1998-12-30 Athlete's foot, eczema prevention and treatment composition containing sagan, cheongpi, fat milk, casualty, Schisandra chinensis extract

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1019980061492A KR100564225B1 (en) 1998-12-30 1998-12-30 Athlete's foot, eczema prevention and treatment composition containing sagan, cheongpi, fat milk, casualty, Schisandra chinensis extract

Publications (2)

Publication Number Publication Date
KR20000044985A true KR20000044985A (en) 2000-07-15
KR100564225B1 KR100564225B1 (en) 2006-06-16

Family

ID=19568240

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019980061492A KR100564225B1 (en) 1998-12-30 1998-12-30 Athlete's foot, eczema prevention and treatment composition containing sagan, cheongpi, fat milk, casualty, Schisandra chinensis extract

Country Status (1)

Country Link
KR (1) KR100564225B1 (en)

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20010103094A (en) * 2001-09-24 2001-11-23 최영범 Soap having a fruit's extraction of maximowiczia typica and method thereof
KR20030065672A (en) * 2002-01-30 2003-08-09 최영진 tabacco improvement
KR100417791B1 (en) * 2000-08-14 2004-02-11 미즈코리아 주식회사 Antibiotic and cosmetic compositions containing herb medicines
WO2006073266A1 (en) * 2005-01-04 2006-07-13 Cj Corporation Compositions for sterilizing spores of spore-forming microorganisms comprising the extracts of torilidis fructus
KR100638055B1 (en) * 2000-03-20 2006-10-24 주식회사 코리아나화장품 Cosmetic compositions containing belamcanda extracts
KR100987975B1 (en) 2008-05-28 2010-10-18 엄용태 Ointment treating for dermatophytosis
CN102973691A (en) * 2012-12-24 2013-03-20 中国人民解放军第一〇一医院 Compound violaxanthin cream and preparation method thereof

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101633184B1 (en) 2014-11-07 2016-06-24 이종걸 Natural herbs soap composition for washing foot and natural herbs soap for washing foot comprising the same

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100638055B1 (en) * 2000-03-20 2006-10-24 주식회사 코리아나화장품 Cosmetic compositions containing belamcanda extracts
KR100417791B1 (en) * 2000-08-14 2004-02-11 미즈코리아 주식회사 Antibiotic and cosmetic compositions containing herb medicines
KR20010103094A (en) * 2001-09-24 2001-11-23 최영범 Soap having a fruit's extraction of maximowiczia typica and method thereof
KR20030065672A (en) * 2002-01-30 2003-08-09 최영진 tabacco improvement
WO2006073266A1 (en) * 2005-01-04 2006-07-13 Cj Corporation Compositions for sterilizing spores of spore-forming microorganisms comprising the extracts of torilidis fructus
US7927632B2 (en) 2005-01-04 2011-04-19 Cj Cheiljedang Corporation Compositions for sterilizing spores of spore-forming microorganisms comprising the extracts of torilidis fructus
KR100987975B1 (en) 2008-05-28 2010-10-18 엄용태 Ointment treating for dermatophytosis
CN102973691A (en) * 2012-12-24 2013-03-20 中国人民解放军第一〇一医院 Compound violaxanthin cream and preparation method thereof

Also Published As

Publication number Publication date
KR100564225B1 (en) 2006-06-16

Similar Documents

Publication Publication Date Title
KR101196745B1 (en) Cosmetic components comprised of the extract from herb extract having anti- P.acnes activity
KR101233857B1 (en) Cosmetic composition with natural orientalplant extract
KR101841181B1 (en) Toothpaste composition comprising herval extract
KR100564225B1 (en) Athlete's foot, eczema prevention and treatment composition containing sagan, cheongpi, fat milk, casualty, Schisandra chinensis extract
KR101930264B1 (en) Cosmetic composition for inhibiting secretion of sebum and for improving acne symptoms containing natural complex extract
US11154580B1 (en) Composition for preventing, ameliorating or treating acne symptoms using natural extracts as active ingredients
KR101894807B1 (en) Antimicrobial composition containing Rosa davurica extract as effective component
KR20200065521A (en) Feminine Cleanser Composition Comprising Natural Antimicrobial Agents
KR101936835B1 (en) Feminine cleanser composition comprising potato or potato pulp extract
KR101954275B1 (en) Cosmetic compositions containing complex extract of gold kiwi peel and dragon fruit peel, and method manufacturing the same
KR102455238B1 (en) Compositions for dandruff and scalp care containing oriental herbal complex extracts
KR101869763B1 (en) Composition for preventing and curing dermatophytosis
KR101917644B1 (en) Feminine cleanser composition comprising fenugreek extract
KR102594674B1 (en) Oral composition comprising herbal complex
KR100645988B1 (en) Antimicrobial body cleanser composition comprising herbal extracts
CN113616801A (en) Preparation method and application of antiseptic and antibacterial preparation containing Scutellariae radix extract
KR20180017974A (en) Cosmetic composition for preventing or treating acne comprising combined herbal extracts
KR20210020817A (en) Antimicrobial composition against acne-inducing bacteria comprising extract of Garcinia mangostana L., and formulation for preventing or treating acne comprising the same
KR101790250B1 (en) Soap composition comprising of medicinal plants
KR20200092042A (en) Method of manufacturing cosmetic composition for curing acnes and cosmetic composition for curing acnes produced by the same
KR20020001931A (en) The cosmetic product containing phellodendri cortex extract and/or schizandrae fructus extract which have anti-acne activity
KR100516448B1 (en) Athlete's foot eczema prevention and treatment composition containing the extract
KR102512244B1 (en) Laundry detergent composition using lactobacillus ferment filtrate and extraction mixture of natural plant and methods for manufacturing the same
KR102561258B1 (en) Composition for controlling sebum and improving pore comprising Jasminum Officinale, Salix Alba (willow) bark and Solanum melogena fruit extract
KR20180035575A (en) A composition comprising Hygrophila megalantha Merr. extracts having anti-inflammation activity

Legal Events

Date Code Title Description
N231 Notification of change of applicant
A201 Request for examination
E902 Notification of reason for refusal
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
LAPS Lapse due to unpaid annual fee